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Neurofibromatosis type 1 (NF-1) is a genetically inherited disorder that may cause skin abnormalities and tumors that form 
on nerve tissues. These tumors can be small or large and can occur anywhere in the body, including the brain, spinal cord, or 
other peripheral nerves. Retroperitoneal lymphangiomas are very rare benign malformations of the lymphatic system. 
About 95% lymphangiomas occur in the skin and the subcutaneous tissues of the head, neck and axillary region and the re-
maining 5% appear in other parts of the body such as lungs, pleura, pericardium, liver, gallbladder, kidney, and the 
mesentery. Herein, we report the case of a giant retroperitoneal lymphangioma in a patient with NF-1 with a review of the 
literature.
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INTRODUCTION
Neurofibromatosis type 1 (NF-1) is a genetically in-
herited disorder that may cause skin abnormalities and tu-
mors that form on nerve tissues. These tumors can be small 
or large and can occur anywhere in the body, including the 
brain, spinal cord, or other peripheral nerves.
Retroperitoneal lymphangiomas are very rare, benign 
malformations of the lymphatic system [1]. About 95% of 
lymphangiomas occur in the skin and the subcutaneous 
tissues of the head, neck and axillary region and the re-
maining 5% appear in other parts of the body such as 
lungs, pleura, pericardium, liver, gallbladder, kidney, and 
the mesentery [2]. 
Herein, we report the case of a giant retroperitoneal 
lymphangioma in a patient with NF-1 with a review of the 
literature.
CASE REPORT
A 59-year-old woman presented with a large, slow- 
growing mobile mass along with abdominal distension. 
She was diagnosed as NF-1 and hypertension five years 
ago.
Physical examination revealed freckling in the axilla Jeong Ho Kim, et al.
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Fig. 1. (A) Chest computed tomography (CT) shows multifocal soft tissue masses with calcification in the bilateral axillae, right pectoralis 
muscle, intermuscular layer of the left posterolateral chest wall. (B) Abdominal CT findings. It shows retroperitoneal giant cystic mass.
Fig. 2. Gross findings shows lymphangioma.  Fig. 3. Microscopic findings show lymphangioma. Proliferation of
anastomosing blood vessels and smooth muscle (H&E,  ×400).
and soft, palpable, fluid-filled mass in the abdomen. There 
were multiple café-au-lait patches and multiple cutaneous 
neurofibromas on the upper extremities and trunk. 
Laboratory studies had no specific findings except for mi-
croscopic hematuria.
Abdominal computed tomography (CT) revealed a 12.4 
× 9 cm sized, well-circumscribed, low-attenuated, large 
cystic mass lesion compressing the adjacent organs with-
out regional lymphadenopathy (Fig. 1). Positron emission 
tomography CT revealed a hypometabolic multiple cystic 
mass in the retroperitoneal space, periheaptic space and 
left lower extremity. No abnormalities were revealed in 
laboratory data including tumor markers such as carci-
noembryonic antigen and carbohydrate antigen 19-9 .
We suspected a benign giant retroperitoneal cyst and 
planned a percutaneous drainage because of its proximity 
to major blood vessels and other organs. The drainage col-
or of lymphorrhea was reddish and not chylous. 
The cytologic analysis revealed mostly red blood cells 
with a few lymphocytes and macrophages. The adenosine 
deaminase level was 12 and acid-fast bacteria stain find-
ings were negative. The fresh blood-like drainage without 
clot formation was continued thereafter. 
After two days, the patient complained of palpitation 
and dizziness. The level of Hb dropped to 9 mg/dL and hy-Retroperitoneal lymphangioma and neurofibromatosis
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potension was checked. On balance, a laparotomy was 
performed. A giant retroperitoneal cystic tumor attached 
to the head of the pancreas and extending to the right kid-
ney was identified. Retroperitoneal resection of the cystic 
mass was conducted successfully. Regarded as doubtful 
bleeding, left renal cystectomy was added concurrently. 
On gross examination, the retroperitoneal mass re-
vealed a well-defined grayish-tan multilocular cystic 
mass. On cut section, there was a large central cystic space, 
measuring 6.0 cm in maximum diameter and the inner 
surface was trabeculated (Fig. 2). The histology showed 
anastomosing blood vessels and proliferation of mature 
fat tissue, and smooth muscle with focal bony ossification, 
displaying a benign vascular tumor (Fig. 3). The central 
cystic lesion was lined by attenuated endothelial cells and 
the periphery showed many dilated and anastomosing 
lymphatic spaces that were lined by endothelial cells. In 
the surrounding stroma, there was mild patchy ag-
gregation of lymphocytes. In immunohistochemical stain-
ing, the lining endothelium was stained with CD34, factor 
VIII related-antigen and α-smooth muscle actin, except 
human melanoma black 45 and cytokeratin. The retro-
peritoneal cystic mass was finally diagnosed as a 
lymphangioma. The patient was discharged 10 days after 
operation without complication.
DISCUSSION
NF-1 is an autosomal dominant genetic disorder that 
causes tumors to grow on the covering of nerves anywhere 
in the body at any time [3]. The disorder affects 1 in 3,000 
males and females of all races and ethnic groups [4]. NF-1 
may affect the gastrointestinal tract in up to 25% of 
patients. 
The incidence of retroperitoneal lymphangioma is very 
low [1]. Much less so, no report is available on lym-
phangioma in a neurofibromatosis patient. Clinical pre-
sentation varies from asymptomatic masses to abdominal 
pain. Symptoms are usually related to tumor size and 
location. If the mass grows large enough to compress ad-
jacent structures and vessels, it can cause significant 
symptoms and morbidities.
The combined use of ultrasonography, CT and mag-
netic resonance imaging is very helpful. But, clinical 
symptoms and radiologic tools may have limitations in ac-
curate diagnosis [5].
Lymphangiomas are classified as simple, cavernous, or 
cystic types based on their histological findings [6,7]. The 
simple type is usually situated superficially in the skin and 
is composed of small thin-walled lymphatic vessels. The 
cavernous type is composed of dilated lymphatic vessels 
and lymphoid stroma, and has a connection with spaces of 
various normal adjacent lymphatics. The cystic type con-
sists of lymphatic spaces.
The differential diagnosis of retroperitoneal lym-
phangiomas must include other fluid-filled lesions such as 
pseudocysts, dermoid cysts, lymphoceles or neoplasms 
like mesotheliomas, pancreatic tumours, lipomas, ter-
atomas, leiomyosarcomas, neurofibromas or liposar-
comas. In addition, lymphangioma should be differ-
entiated from hemagioma in case secondary hemorrhage 
is present.
Beyond all things, it is important to distinguish in-
tra-abdominal lymphangioma from cystic forms of 
malignancy. 
Lymphangioma is characterized by stromal aggregates 
of lymphocytes, an endothelial lining that usually stains 
positively with factor VIII-related antigen or CD31, and 
that is often surrounded by a layer of smooth muscle tissue 
[8]. In this case report, the appearance of retroperitoneal 
lymphangioma at the abdominal CT scanning and distinc-
tive pathologic findings are illustrated.
Some authors recommended conservative manage-
ment in asymptomatic patients, based on a 10% sponta-
neous regression rate [8]. 
Although lymphangioma is a benign neoplasm, a larger 
or symptomatic lymphangioma is treated with resection 
to prevent recurrence, infection, torsion, rupture and 
enlargement. Surgery is often required for symptom con-
trol or diagnosis. 
The definitive treatment of lymphangioma is complete 
surgical excision. Retroperitoneal cysts are technically 
more difficult to excise completely because of their prox-
imity to major blood vessels and other organs. Retroperi-
toneal cysts are often incompletely excised and require Jeong Ho Kim, et al.
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multiple operations. For the most part, it should be noted 
that the 10% postoperative recurrence rate is due to in-
complete resection as evinced by positive microscopic re-
section margins [9].
Aspiration and injection of sclerosing agents such as al-
cohol and polidocanol into lymphangioma may be recom-
mended in nonsurgical candidates for emergency decom-
pression [10].
In this case, a 12 cm-sized giant retroperitoneal lym-
phangioma and left renal cyst were surgically removed 
without any complication. Our case may be the first re-
ported case of lymphangioma in a patient of NF-1.
From this case and literature, we can conclude that an 
accurate preoperative diagnosis of retroperitoneal lym-
phangioma in a patient with NF-1 is highly exceptional. 
Mass resection should be performed whenever possible. 
To prevent recurrence, complete excision of the retro-
peritoneal cystic lymphangioma is mandatory.
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